Molecular aspects of invasion and metastasis of stomach cancer
- PMID: 11217448
Molecular aspects of invasion and metastasis of stomach cancer
Abstract
The scenario of multiple genetic and epigenetic alterations found in gastric carcinoma differs depending upon the two histological types, indicating that well differentiated or intestinal type and poorly differentiated or diffuse type gastric carcinomas have different genetic pathways. Cancer-stromal interaction through growth factor/cytokine receptor system which plays a central role in invasion and metastasis, is also different between the two types of stomach cancer. The majority of gastric carcinoma exhibit co-expression of IL-8 and its two receptors that evidently confer tumor angiogenesis. IL-8 increases the expression of EGF receptor, VEGF and IL-8 itself by tumor cells themselves, whereas IL-8 decreases expression of E-Cadherin, associated with increase in expression and activity of MMP-9 by tumor cells. These findings overall suggest that IL-8 produced by gastric cancer cells is used for sustained angiogenesis and tissue invasion and metastasis via autocrine/paracrine manners. On the other hand, co-expression of osteopontin (OPN) and CD44v9 in tumor cells correlates well with the degree of lyiphatic vessel invasion or long distant lymph node metastasis in diffuse type gastric carcinoma, indicating that mutual interaction between OPN and CD44v9 on the tumor cells is implicated in lymphogenous metastasis. In addition to these factors, tumor invasion and metastasis requires telomere maintenance regulated by telomerase activity. The human telomerase catalytic subunit, hTERT, is strongly expressed in almost all primary tumors and nodal metastasis.
Similar articles
-
Genetic pathways of two types of gastric cancer.IARC Sci Publ. 2004;(157):327-49. IARC Sci Publ. 2004. PMID: 15055305 Review.
-
Cancer-stromal interaction through growth factor/cytokine networks implicated in growth of stomach cancer.Princess Takamatsu Symp. 1994;24:187-94. Princess Takamatsu Symp. 1994. PMID: 8983075 Review.
-
Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.Carcinogenesis. 2009 Oct;30(10):1660-9. doi: 10.1093/carcin/bgp178. Epub 2009 Jul 22. Carcinogenesis. 2009. PMID: 19625348
-
Molecular biological observations in gastric cancer.Semin Oncol. 1996 Jun;23(3):307-15. Semin Oncol. 1996. PMID: 8658214 Review.
-
Genetic and epigenetic alterations in multistep carcinogenesis of the stomach.J Gastroenterol. 2000;35 Suppl 12:111-5. J Gastroenterol. 2000. PMID: 10779229
Cited by
-
The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.Diagn Pathol. 2015 Jul 28;10:128. doi: 10.1186/s13000-015-0356-3. Diagn Pathol. 2015. PMID: 26215716 Free PMC article.
-
Stat3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells.Dig Dis Sci. 2009 Oct;54(10):2056-62. doi: 10.1007/s10620-008-0617-z. Epub 2008 Dec 11. Dig Dis Sci. 2009. PMID: 19082717
-
Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.Oncotarget. 2016 Jul 5;7(27):41404-41420. doi: 10.18632/oncotarget.9167. Oncotarget. 2016. PMID: 27167343 Free PMC article.
-
A Novel Telomere Maintenance Gene-Related Model for Prognosis Prediction in Gastric Cancer.Biochem Genet. 2025 May 20. doi: 10.1007/s10528-025-11132-0. Online ahead of print. Biochem Genet. 2025. PMID: 40392448
-
Altered expression of Krüppel-like factor 4 and β-catenin in human gastric cancer.Oncol Lett. 2012 May;3(5):1017-1022. doi: 10.3892/ol.2012.619. Epub 2012 Feb 28. Oncol Lett. 2012. PMID: 22783383 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous